| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2B | $8.1B | $7.7B | $7.7B | $12.8B | $16.3B | $16.6B | $17.3B |
| Cost of Revenue | — | — | — | — | — | $7.9B | $8.3B | $9.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | $0.7B | $1.3B | $2.2B | $1.8B | — |
| Operating Income | $0.7B | $0.7B | $0.1B | $0.0B | $0.2B | $0.4B | $0.8B | $0.7B |
| Net Income | $0.3B | $0.4B | $0.2B | $0.7B | $0.3B | $0.1B | $0.4B | $0.4B |
| EPS (Basic) | $2.69 | $3.33 | $0.50 | $-0.81 | $1.06 | $0.87 | $3.95 | $3.17 |
| EPS (Diluted) | $2.64 | $3.23 | $0.49 | $-0.81 | $1.05 | $0.78 | $3.57 | $2.88 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.2B | $7.7B | $7.5B | $6.3B | $8.7B | $16.2B | $14.1B | $12.3B |
| Current Assets | $1.6B | $1.5B | $1.6B | $1.6B | $2.7B | $5.4B | $3.3B | $3.7B |
| Cash & Equivalents | $0.3B | $0.2B | $0.4B | $0.5B | $0.3B | $2.1B | $0.4B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.6B | $1.4B | $1.6B | $1.5B | $2.5B | $5.2B | $3.3B | $3.3B |
| Stockholders' Equity | $1.9B | $1.6B | $1.3B | $1.0B | $1.1B | $2.7B | $2.7B | $3.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | — | $0.7B | $0.9B | $0.8B | $1.1B |
| Investing Cash Flow | — | — | — | — | $-0.2B | $-0.4B | $-0.2B | $-0.4B |
| Capital Expenditures | $0.7B | $0.8B | $1.5B | $0.5B | $0.3B | $0.5B | $0.6B | $0.6B |
| Financing Cash Flow | — | — | — | — | $-1.9B | $1.1B | $-0.8B | $-0.6B |